Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    22155172 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Rifaximin-EIR

Study has passed its completion date and status has not been verified in more than two years.